FDA approves a cholesterol pill unlike anything before
The Food and Drug Administration has approved Lipfendra, the first oral PCSK9 inhibitor for treating high cholesterol, including a genetic form known as familial hypercholesterolemia. Manufactured by Merck, the once daily pill offers patients an alternative to the injectable versions of this drug class that have been available for years, and it is expected to […]